Publication | Closed Access
BIG 1–98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer
120
Citations
0
References
2005
Year
Endocrine OncologyBreast OncologyHealth SciencesMedicineClinical TrialsGynecologyReceptor-positive Breast CancerBreast CancerPharmacotherapyMenopauseBig 1–98Menopause Hormone TherapyOncologyRadiation OncologyEndocrine-related CancerWomen's HealthPostmenopausal Women
511